Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro

Overview of attention for article published in BMC Cancer, April 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

NOVEL CLASS OF MONOSPECIFIC AND BISPECIFIC HUMANIZED ANTIBODIES THAT TARGET THE INSULIN-LIK…

Application EP-3075390-A1

European Patent Office

NOVEL CLASS OF MONOSPECIFIC AND BISPECIFIC HUMANIZED ANTIBODIES THAT TARGET THE INSULIN-LIK…

Application EP-2525820-A4

European Patent Office

NOVEL CLASS OF MONOSPECIFIC AND BISPECIFIC HUMANIZED ANTIBODIES THAT TARGET THE INSULIN-LIK…

Application EP-2525820-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.